Read More
Lifestyle Medicine Cancer Misc

New Research Publication: OliFuco® Oligo Fucoidan as an Adjunct Therapy for Lung Cancer

IHi-Q is pleased to announce the publication of our study investigating the use of OliFuco® Oligo Fucoidan, our proprietary ingredient, as an adjunct therapy for lung cancer. Given lung cancer’s high incidence and mortality rates, particularly in Taiwan, our research focused on evaluating how adding OliFuco® to conventional treatments could impact patient outcomes. Study Overview: Participants: NSCLC patients aged […]